Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein

G.J. Schuurhuis; H.J. Broxterman; J.H.M. de Lange; H.M. Pinedo; H.M. van Heijningen; C.M. Kuiper; G.L. Scheffer; R.J. Scheper; C.K. van Kalken; J. Lankelma

Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein

G.J. Schuurhuis
, H.J. Broxterman
, J.H.M. de Lange
, H.M. Pinedo
, H.M. van Heijningen
, C.M. Kuiper
, G.L. Scheffer
, R.J. Scheper
, C.K. van Kalken
, J. Lankelma

Research output: Contribution to journal › Article › Academic › peer-review

15 Downloads (Pure)

Original language	English
Pages (from-to)	857-861
Journal	British journal of cancer
Volume	64
Publication status	Published - 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

8420Final published version, 5.44 MB

Cite this

@article{cda128c44a6443f288768f207de39193,

title = "Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein",

author = "G.J. Schuurhuis and H.J. Broxterman and \{de Lange\}, J.H.M. and H.M. Pinedo and \{van Heijningen\}, H.M. and C.M. Kuiper and G.L. Scheffer and R.J. Scheper and \{van Kalken\}, C.K. and J. Lankelma",

year = "1991",

language = "English",

volume = "64",

pages = "857--861",

journal = "British journal of cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein

AU - Schuurhuis, G.J.

AU - Broxterman, H.J.

AU - de Lange, J.H.M.

AU - Pinedo, H.M.

AU - van Heijningen, H.M.

AU - Kuiper, C.M.

AU - Scheffer, G.L.

AU - Scheper, R.J.

AU - van Kalken, C.K.

AU - Lankelma, J.

PY - 1991

Y1 - 1991

M3 - Article

SN - 0007-0920

VL - 64

SP - 857

EP - 861

JO - British journal of cancer

JF - British journal of cancer

ER -